| miRNA | microRNA |
| siRNA | small interfering RNA |
| mRNA | messenger RNA |
| LNA | locked nucleic acid |
| AGO | Argonaute protein |
| RISC | RNA-induced silencing complex |
| NV | nanovector |
| NP | nanoparticle |
| PEG | polyethylene glycol |
| PLGA | poly(lactic-co-glycolic acid) |
| EV | extracellular vesicles |
| FDA | Food and drug administration of Unites States |
| EMA | European medicine agency |
| PA | pulmonary artery |
| PH | pulmonary hypertension |
| PAH | pulmonary artery hypertension |
| UTR | untranslated region |
| PAEC | pulmonary artery endothelial cell |
| HPAEC | human pulmonary artery endothelial cell |
| PASMC | pulmonary artery smooth muscle cell |
| HPASMC | human pulmonary artery smooth muscle cell |
| PAF | pulmonary artery fibroblast |
| HIF-1 α | hypoxia inducible factor 1-alpha |
| BMPR2 | bone morphogenetic protein receptor type II |
| mTOR | mammalian target of rapamycin |
| PTPB1 | polypyrimidine tract-binding protein 1 |
| PKM1/M2 | pyruvate kinase isozymes M1/M2 |
| SMAD3 | mothers against decapentaplegic homolog 3 |
| TGFBR2 | transforming growth factor beta receptor 2 |
| α-SMA | Alpha-smooth muscle actin |
| SMAD2/7 | mothers against decapentaplegic homolog 2/7 |
| MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 |
| ERK1/2 | extracellular signal-regulated kinase ½ |
| FHL-1 | four and a half LIM domain protein |
| CCNL2 | cyclin-L2 |
| LMOD1 | leiomodin 1 |
| MEF2C | myocyte-specific enhancer factor 2C |
| PTEN | phosphatase and tensin homolog |
| FGF | fibroblast growth factor |
| MYC | master regulator of cell entry and proliferative metabolism |
| HDAC4 | histone deacetylase 4 |
| CDK6 | cell division protein kinase 6 |